The settlement resolves the Attorney General’s 2018 lawsuit alleging that Novo Nordisk deceptively priced its insulin.

NHS advice: Fiasp Penfill (insulin aspart ... he had been unable to access his regular pre-filled Tresiba insulin pen 'for the last six prescriptions now'. Another, who was forced to switch ...

For five years, insulin manufacturer Novo Nordisk agrees to cap out-of-pocket cost of its insulin treatments at $35 per month, and provide free insulin to the neediest Minnesotans.